-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
TheraDiag
Identification
Instrument name
THERADIAG
Symbol
ALTER
ISIN code
FR0004197747
Exchange / Market
Euronext Growth
Trading location
Paris
Products family
Stocks
Market organization
Alternext
ICB
Biotechnology
Activity description
TheraDiag (ex Biomedical Diagnostics) est spécialisé dans le développement, la fabrication et la commercialisation de kits de diagnostics in-vitro destinés à la détection des maladies auto-immunes, des allergies et des maladies infectieuses. En outre, le groupe propose des tests de théranostic dédiés à monitorer les biothérapies et à déterminer la réponse des patients aux traitements reçus.
Source Cofisem
Website address
http://www.theradiag.com
Operation
IPO date
Tue 11/12/2012
IPO type
Introduction par offre au public
IPO type
Initial Public offering
Catégorie
IPO
Operation calendar
Listing date: 05/12/2012
First trading date: 11/12/2012
Price range
Fourchette de prix indicative : 4,80 EUR - 5,80 EUR